이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

An Observational Study of the Medical-Grade Wireless Wearable Data for Predicting Hypoxemia Risk and Evaluating Workflow Efficiency in Patients Undergoing Sedated Gastrointestinal Endoscopy

2026년 11월 15일 업데이트: Min Su

This prospective observational study aims to develop and evaluate prediction models for low blood oxygen levels (hypoxemia) in adult patients undergoing gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia. The study will also assess patient flow and waiting times during different stages of endoscopy care.

Low blood oxygen levels may occur during anesthesia and recovery from endoscopy. Medical-grade wireless wearable monitoring devices can continuously record vital signs as patients move through preparation, examination, transfer, and recovery areas. The investigators will analyze monitoring data, routine clinical information, and the time spent at different stages of care to identify factors associated with hypoxemia and potentially avoidable nonmedical waiting time.

This study will be conducted at the First Affiliated Hospital of Chongqing Medical University. Approximately 772 adult participants are planned for enrollment in the current study phase. All participants will receive routine anesthesia, endoscopy, monitoring, and recovery care. The study will not change clinical treatment decisions, and prediction model results will not be used to guide patient care.

The findings may support future improvements in patient safety monitoring, hypoxemia risk assessment, and endoscopy workflow efficiency. Participants may not receive any direct medical benefit from taking part in this study.

연구 개요

상태

아직 모집하지 않음

상세 설명

Background and Rationale Hypoxemia is an important safety concern during gastrointestinal endoscopy under anesthesia. Changes in oxygen saturation may occur during both the procedure and the recovery period. Continuous monitoring using medical-grade wireless wearable devices may provide useful physiological data for predicting hypoxemia. In addition, the time required for different stages of endoscopy care may be influenced by patient characteristics, clinical needs, and operational factors. Distinguishing medically necessary care from avoidable nonmedical waiting may help improve workflow efficiency without compromising patient safety.

Study Design and Data Collection This investigator-initiated, prospective observational cohort study will be conducted at the First Affiliated Hospital of Chongqing Medical University. The current phase involves single-center model development and internal validation.

Adult patients scheduled for gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia will be assessed for eligibility and enrolled after written informed consent.

Medical-grade wireless wearable monitoring devices already used in routine clinical care will provide continuous physiological data, including peripheral oxygen saturation (SpO2), heart rate, and signal quality information. Additional study data will include routine pre-anesthesia assessments, patient characteristics, anesthesia and endoscopy records, airway management, recovery information, and workflow timestamps. Simple noninvasive measurements, including neck circumference and thyromental distance, will also be collected.

Hypoxemia Prediction Two prediction objectives will be evaluated. Model A will use information available before the first administration of anesthetic medication to predict hypoxemia occurring between the first anesthetic dose and endoscope removal.

Model B will evaluate the risk of hypoxemia during recovery, from completion of handover to the recovery area until the patient first meets discharge criteria. Development of Model B will depend on the availability of sufficient outcome events and data.

Hypoxemia will be defined as an SpO2 below 90%, after excluding measurement artifacts. Prediction models will be developed and internally validated using prespecified statistical and machine-learning methods. Additional temporal and external validation may be conducted in subsequent study phases after the required approvals.

Workflow Efficiency Assessment Standardized timestamps will be collected across patient check-in, preparation, monitoring, examination, transfer, recovery, discharge, and room turnover. Risk-adjusted analyses will assess variations in the duration of different workflow stages.

The main workflow efficiency outcome will be the cumulative duration of system-attributable nonmedical waiting time, confirmed by structured documentation of operational causes. Time required for necessary medical treatment, monitoring, and recovery will not be classified as avoidable waiting.

Patient Safety and Study Procedures This study is observational and will not alter routine anesthesia, endoscopy, monitoring, treatment, recovery, or discharge decisions. Prediction model results will not be disclosed to the clinical team for decision-making during the current study phase.

Research data will be de-identified and handled using appropriate data protection procedures. Available hospital records may be reviewed within 24 hours after discharge from the endoscopy center to identify relevant safety events. No additional invasive procedures or study-directed treatments will be performed.

연구 유형

관찰

등록 (추정된)

772

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, 중국, 400016
        • The First Affiliated Hospital of Chongqing Medical University
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

The study population will consist of adult patients aged 18 years or older who are scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia at the First Affiliated Hospital of Chongqing Medical University, China. Potential participants will be identified through routine pre-anesthesia assessment and outpatient clinical services. Eligible patients with an ASA-PS classification of I-III who receive routine medical-grade wireless wearable monitoring will be invited to participate after screening. Written informed consent will be obtained before enrollment. Approximately 772 participants are planned for the current single-center observational study.

설명

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia, with routine medical-grade wireless wearable monitoring.
  • American Society of Anesthesiologists Physical Status (ASA-PS) classification I-III before anesthesia.
  • Able to understand the study information, voluntarily agree to participate, and provide written informed consent.

Exclusion Criteria:

  • Refusal to participate in the study.
  • Emergency endoscopy.
  • Preprocedural hypoxemia requiring advanced respiratory support.
  • Uncontrolled severe cardiopulmonary disease before the procedure.
  • Requirement for general anesthesia with endotracheal intubation, intensive care unit (ICU)-level support, or planned transfer to the ICU after the procedure.
  • Active major bleeding, a clearly full stomach, an anticipated difficult airway requiring a special anesthetic strategy, or other extremely high-risk conditions unsuitable for routine anesthesia management in an endoscopy center.
  • Missing critical outcome information that prevents determination of the primary safety outcome.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
Patients Undergoing Gastrointestinal Endoscopy Under Anesthesia

This cohort consists of adult patients aged 18 years or older who are scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia at the First Affiliated Hospital of Chongqing Medical University. Eligible patients have an American Society of Anesthesiologists Physical Status (ASA-PS) classification of I-III and provide written informed consent. All participants receive routine anesthesia, endoscopic examination, and medical-grade wireless wearable monitoring according to standard clinical practice. Physiological monitoring data, clinical information, and workflow timestamps will be collected prospectively for hypoxemia prediction model development and workflow efficiency assessment. No additional study-directed clinical intervention will be performed.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Incidence of Hypoxemia During Gastrointestinal Endoscopy
기간: From the first administration of anesthetic medication until endoscope removal, during the endoscopy procedure.

The proportion of participants experiencing at least one episode of hypoxemia between the first administration of anesthetic medication (T6) and endoscope removal (T8). Hypoxemia is defined as peripheral oxygen saturation (SpO2) below 90% at any time, after exclusion of measurement artifacts caused by movement, poor perfusion, or sensor displacement. Events will be adjudicated using monitoring data and clinical records.

From the first administration of anesthetic medication until endoscope removal, during the endoscopy procedure.
Cumulative System-Attributable Nonmedical Waiting Time
기간: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

The cumulative duration, in minutes, of system-attributable nonmedical waiting time per participant. Waiting episodes must have a documented operational cause, traceable start and end times, and no ongoing medical need for treatment, observation, or technical management. Operational causes include delays related to equipment, procedure rooms, staffing, recovery beds, transportation, handover, documentation, patient education, accompanying persons, cleaning, or supply preparation. Medically necessary care and recovery time will be excluded.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

2차 결과 측정

결과 측정
측정값 설명
기간
Incidence of Hypoxemia During Postanesthesia Recovery
기간: From completion of handover to the postanesthesia recovery area until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of eligible participants experiencing hypoxemia (SpO2 below 90%, after artifact exclusion) after completion of handover to the recovery area (T10) and before first meeting discharge criteria (T12). The analysis will include participants without the recovery-period target event at T10 who have the required landmark variables. Formal model development is conditional on sufficient outcome events.

From completion of handover to the postanesthesia recovery area until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Severe Hypoxemia
기간: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants experiencing severe hypoxemia, defined as SpO2 below 75%, or SpO2 between 75% and 90% lasting at least 60 seconds, according to the study protocol.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Ratio of Hypoxemia Area Under the Curve to Duration
기간: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The area under the SpO2 curve for measurements below 90% divided by the cumulative duration of SpO2 below 90%, according to the prespecified analysis methodology.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Clinically Recognized Respiratory Events
기간: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The number and proportion of participants with clinically recognized apnea, airway obstruction, laryngospasm, bronchospasm, regurgitation, or aspiration. Event types will be reported separately.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Airway Interventions
기간: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The number and proportion of participants requiring positional adjustment, jaw thrust, increased oxygen flow, oropharyngeal or nasopharyngeal airway placement, positive-pressure mask ventilation, or unplanned tracheal intubation. Intervention types will be reported separately.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Hypotension
기간: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants with systolic blood pressure below 90 mmHg or a decrease greater than 30% from baseline. Treatment for hypotension will also be documented.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Bradycardia
기간: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants with heart rate below 50 beats per minute. Treatment for bradycardia will also be documented.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Occurrence of Major Clinical Complications
기간: From check-in at the endoscopy center through 24 hours after actual departure from the endoscopy center.

The number and type of major clinical complications, including severe gastrointestinal bleeding, gastrointestinal perforation, unplanned emergency department transfer, intensive care unit admission or hospitalization, cardiac arrest, and death. Individual event categories will be reported separately.

From check-in at the endoscopy center through 24 hours after actual departure from the endoscopy center.
Total Endoscopy Center Length of Stay
기간: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

Total time in minutes from endoscopy center check-in (T1) to actual departure from the endoscopy center (T13).

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.
Duration of Individual Endoscopy Workflow Stages
기간: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each consecutive workflow stage will be assessed separately.

Duration in minutes of each adjacent workflow stage from T1 through T13, including preparation, examination, transfer, recovery, and discharge-related stages. Stage-specific values will be reported.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each consecutive workflow stage will be assessed separately.
Procedure Room Turnover Time
기간: From departure of the participant from the procedure area until the next patient enters the same procedure room, on the day of the endoscopy procedure.

Time in minutes from a participant leaving the procedure area (T9) until the next patient enters the same procedure room (T14). Prespecified exceptions will be excluded or reported separately.

From departure of the participant from the procedure area until the next patient enters the same procedure room, on the day of the endoscopy procedure.
Risk-Adjusted Excess Workflow Duration
기간: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each workflow stage will be evaluated separately.

The difference between observed and expected workflow duration estimated using prespecified risk-adjusted stage-specific time models. Results will be evaluated by workflow stage.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each workflow stage will be evaluated separately.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Su Min, First Affiliated Hospital of Chongqing Medical University

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 12월 1일

기본 완료 (추정된)

2028년 4월 30일

연구 완료 (추정된)

2028년 4월 30일

연구 등록 날짜

최초 제출

2026년 11월 7일

QC 기준을 충족하는 최초 제출

2026년 11월 15일

처음 게시됨 (실제)

2026년 11월 18일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 18일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 15일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

De-identified individual participant data (IPD) may be made available upon reasonable request to the corresponding author following publication of the primary study findings. Data sharing will be subject to approval by the relevant institutional ethics committee and execution of a data use agreement.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다